The HIV care cascade: Japanese perspectives
Open Access
- 20 March 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (3), e0174360
- https://doi.org/10.1371/journal.pone.0174360
Abstract
Japan has been known as a low HIV-prevalence country with a concentrated epidemic among high-risk groups. However, it has not been determined whether Japan meets the 90-90-90 goals set by the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO). Moreover, to date, the HIV care cascade has not been examined. We estimated the total number of diagnosed people living with HIV/AIDS (PLWHA) (n = 22,840) based on legal reports to the Ministry of Health, Labour and Welfare by subtracting the number of foreigners who left Japan (n = 2,273) and deaths (n = 2,321) from the cumulative diagnosis report (n = 27,434). The number of total undiagnosed PLWHA was estimated by age and sex specific HIV-positive rates observed among first-time blood donors between 2011–2015 in Japan. Our estimates show that 14.4% (n = 3,830) of all PLWHA (n = 26,670) were undiagnosed in Japan at the end of 2015. The number of patients retained in care (n = 20,615: 77.3% of PLWHA), the percentage of those on antiretroviral therapy (n = 18,921: 70.9% of PLWHA) and those with suppressed viral loads (<200 copies/mL; n = 18,756: 70.3% of PLWHA) were obtained through a questionnaire survey conducted in the AIDS Core Hospitals throughout the country. According to these estimates, Japan failed to achieve the first two of the three UNAIDS/WHO targets (22,840/26,670 = 85.6% of HIV-positive cases were diagnosed; 18,921/22,840 = 82.8% of those diagnosed were treated; 18,756/18,921 = 99.1% of those treated experienced viral suppression). Although the antiretroviral treatment uptake and success after retention in medical care appears to be excellent in Japan, there are unmet needs, mainly at the surveillance level before patients are retained in care. The promotion of HIV testing and treatment programs among the key affected populations (especially men who have sex with men) may contribute to further decreasing the HIV epidemic and achieving the UNAIDS/WHO targets in Japan.Keywords
Funding Information
- Ministry of Health, Labour and Welfare (H27-AIDS-SHITEI-005)
- Ministry of Health, Labour and Welfare (H27-AIDS-SHITEI-004)
This publication has 24 references indexed in Scilit:
- The HIV care cascade: models, measures and moving forwardJournal of the International AIDS Society, 2015
- Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break pointsJournal of the International AIDS Society, 2014
- HIV Care Visits and Time to Viral Suppression, 19 U.S. Jurisdictions, and Implications for Treatment, Prevention and the National HIV/AIDS StrategyPLOS ONE, 2013
- Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patientsAIDS, 2013
- HIV Treatment as Prevention: Natural Experiments Highlight Limits of Antiretroviral Treatment as HIV PreventionPLoS Medicine, 2012
- Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based studyThe Lancet, 2010
- Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San FranciscoPLOS ONE, 2010
- HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidityBMJ, 2009
- Numbers of People with HIV/AIDS Reported and Not Reported to Surveillance in JapanJournal of Epidemiology, 2004
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997